ArticleArchives of virology2025
Genome sequencing of Pasteurella multocida phage PMP1 elucidates a possible host resistance mechanism and suggests that it belongs to a new species.
Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Isolation, characterization, and antibacterial activity of a novel Pasteurella multocida bacteriophage.Poultry science · 2026Article
- Phages for One Health: regulatory and product life cycle considerations.Microbiology (Reading, England) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Pasteurella multocida, especially capsular serotype A, is a zoonotic pathogen that is found mainly in livestock. While antibiotics are commonly used to treat bacterial infections, bacteriophage therapy has become an important alternative due to the issue of antibiotic resistance. Although four virulent P. multocida-infecting phages have been described, their interactions with their hosts have not been extensively studied. In this study, a novel virulent phage, PMP1, was isolated from a livestock waste treatment facility in Korea. This phage has a short, non-contractile tail with an isometric head and specifically lyses toxA-negative serotype A strains but can adsorb to toxA-positive strains. PMP1 has a genome of 38,049 bp in length with no genes related to lysogeny. Bioinformatic analysis and transmission electron microscopy suggest that a toxA-containing prophage could be involved in the restriction-modification system; however, the correlationof the presence of toxA with phage resistance was not clearly established. The structural proteins were identified for the first time in a P. multocida-infecting phage by LC-MS/MS analysis, and phylogenetic analysis revealed that PMP1 could be a member of new species in the genus Wuhanvirus. These findings suggest that this phage should be investigated further as a potential anti-P. multocida agent.
Indexed as
Identifiers
40637897What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.